Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Murray

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Intervirology|February 27, 2003
RNA bacteriophage capsid-mediated drug delivery and epitope presentationWilliam L Brown, Robert A Mastico, Min Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 6, 2005
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SARChristine M Richardson, Douglas S Williamson, Martin J Parratt, et al.
BMC Medicine|March 7, 2019
The cost of diagnostic uncertainty: a prospective economic analysis of febrile children attending an NHS emergency departmentSimon Leigh, Alison Grant, Nicola Murray, et al.
Chemmedchem|February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 InhibitorsSzabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Structure-guided design of alpha-amino acid-derived Pin1 inhibitorsAndrew J Potter, Stuart Ray, Louisa Gueritz, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolutionAndrew Potter, Victoria Oldfield, Claire Nunns, et al.
ACS Omega|September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its AnaloguesSzabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
Journal of Medicinal Chemistry|October 23, 2024
Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo ActivityAttila Vasas, Lisa Ivanschitz, Balázs Molnár, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Intervirology|February 27, 2003
RNA bacteriophage capsid-mediated drug delivery and epitope presentationWilliam L Brown, Robert A Mastico, Min Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 6, 2005
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SARChristine M Richardson, Douglas S Williamson, Martin J Parratt, et al.
BMC Medicine|March 7, 2019
The cost of diagnostic uncertainty: a prospective economic analysis of febrile children attending an NHS emergency departmentSimon Leigh, Alison Grant, Nicola Murray, et al.
Chemmedchem|February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 InhibitorsSzabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Structure-guided design of alpha-amino acid-derived Pin1 inhibitorsAndrew J Potter, Stuart Ray, Louisa Gueritz, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolutionAndrew Potter, Victoria Oldfield, Claire Nunns, et al.
ACS Omega|September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its AnaloguesSzabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
Journal of Medicinal Chemistry|October 23, 2024
Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo ActivityAttila Vasas, Lisa Ivanschitz, Balázs Molnár, et al.
Pageof 4